Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Detection of Sacral Fractures on Radiographs Using Artificial Intelligence.
Inagaki N, Nakata N, Ichimori S, Udaka J, Mandai A, Saito M. Inagaki N, et al. Among authors: ichimori s. JB JS Open Access. 2022 Sep 14;7(3):e22.00030. doi: 10.2106/JBJS.OA.22.00030. eCollection 2022 Jul-Sep. JB JS Open Access. 2022. PMID: 36128254 Free PMC article.
Comparison of the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) and long-acting second-generation basal insulin (insulin degludec and insulin glargine 300 units/mL) in insulin-naïve Japanese adults with type 2 diabetes: a pilot, randomized, controlled study.
Shimoda S, Sakamoto W, Hokamura A, Matsuo Y, Sekigami T, Ichimori S, Iwashita S, Ishii N, Otsu K, Yoshimura R, Nishiyama T, Sakaguchi M, Nishida K, Araki E. Shimoda S, et al. Among authors: ichimori s. Endocr J. 2019 Aug 29;66(8):745-752. doi: 10.1507/endocrj.EJ19-0179. Epub 2019 Jul 12. Endocr J. 2019. PMID: 31308304 Free article. Clinical Trial.
A 1-year, prospective, observational study of Japanese outpatients with type 1 and type 2 diabetes switching from insulin glargine or detemir to insulin degludec in basal-bolus insulin therapy (Kumamoto Insulin Degludec Observational study).
Shimoda S, Sato M, Sekigami T, Motoshima H, Yoshimura R, Fukuda K, Matsuo Y, Noda H, Okubo M, Ichimori S, Fujisawa K, Fukunaga M, Araki E; Kumamoto Insulin Degludec Observational (KIDUNA) Study Group. Shimoda S, et al. Among authors: ichimori s. J Diabetes Investig. 2016 Sep;7(5):703-10. doi: 10.1111/jdi.12496. Epub 2016 Mar 19. J Diabetes Investig. 2016. PMID: 27181264 Free PMC article.
Comparison of the efficacy of sitagliptin and glimepiride dose-up in Japanese patients with type 2 diabetes poorly controlled by sitagliptin and glimepiride in combination.
Shimoda S, Iwashita S, Sekigami T, Furukawa N, Matsuo Y, Ichimori S, Goto R, Maeda T, Watanabe E, Kondo T, Matsumura T, Motoshima H, Nishida K, Araki E. Shimoda S, et al. Among authors: ichimori s. J Diabetes Investig. 2014 May 4;5(3):320-6. doi: 10.1111/jdi.12151. Epub 2013 Oct 22. J Diabetes Investig. 2014. PMID: 24843781 Free PMC article.
Efficacy and safety of sitagliptin as add-on therapy on glycemic control and blood glucose fluctuation in Japanese type 2 diabetes subjects ongoing with multiple daily insulin injections therapy.
Shimoda S, Iwashita S, Ichimori S, Matsuo Y, Goto R, Maeda T, Matsuo T, Sekigami T, Kawashima J, Kondo T, Matsumura T, Motoshima H, Furukawa N, Nishida K, Araki E. Shimoda S, et al. Among authors: ichimori s. Endocr J. 2013;60(10):1207-14. doi: 10.1507/endocrj.ej13-0198. Epub 2013 Aug 3. Endocr J. 2013. PMID: 23912974 Free article. Clinical Trial.
11 results